Thymidine

Europe PMC · fetched just now · sorted by publication date

1. 1
   Oral delivery of recombinant <i>Lactococcus lactis</i> expressing an IL-23 inhibitor as a potential therapeutic strategy for experimental colitis.

   Kopecna E, Raskova Kafkova L, Kosztyu P, Sloupenska K, Zachova K, Cutkova A, Skarda J, Vaculova J, Kuchar M, … · 2026-10-03

   open access unreviewed
2. 2
   Human-biased <i>MEIS1</i> expression by a promoter noncoding RNA regulates neural stem cell proliferation.

   Uchida H, Kameda T, Zenno S, Nakashima H, Minato Y, Aritsuka Y, Nishida S, An B, Honda M, Morishita F, Nakash… · 2026-09-30

   open access unreviewed
3. 3
   MicroRNA circuits and regulatory networks: emerging therapeutic paradigm.

   Goswami S, Singh S. · 2026-09-25

   open access unreviewed
4. 4
   Discovery of the nucleoside analogue FMAU as a broad-spectrum anti-orthopoxvirus inhibitor in vitro and in vivo using a structure-guided hit expansion strategy.

   Zheng T, Feng Y, Xu C, Kouam AF, Chen S, Eshboev F, Liu Y, Wang F, Yang Y, Qi J, Fu L. · 2026-09-22

   open access unreviewed
5. 5
   Genotoxicity and sub-chronic oral toxicity of a blend of bacteriophage for animal feeds.

   Portocarero N, Sung K, Kim Y, Seo R. · 2026-08-20

   open access unreviewed
6. 6
   What do we know about redox status? A review in neonates of mothers with preeclampsia.

   Avilés-Garcia JC, Aguilar-Dueñas MF, Ceballos G, Torres-Ramos YD. · 2026-08-26

   open access unreviewed
7. 7
   Molecular cloning of a monkeypox virus clade IIb genome and construction of an attenuated mutant for basic and translational research.

   Klatt V, Meyer Zu Natrup C, Staliunaite L, Clever S, Knickmann J, Ohrnberger S, Seib J, Ostermann E, Weichel … · 2026-08-26

   open access unreviewed
8. 8
   Cryptotanshinone inhibits <i>Staphylococcus aureus</i> NdhC via uncompetitive inhibition: Collateral sensitivity in respiratory-deficient SCVs.

   Xue ZJ, Huang MY, Wang JF, Zhong SY, Yang ZC, Xu J, Jin B, Chen NP, Qian CD. · 2026-08-30

   open access unreviewed
9. 9
   HSV-1 metabolic hijacking: Mechanisms to precision therapeutics.

   Kuang S, Zhang J, Chen J, He Z, Yang J, Li S, Ding J, Ma Z, Zhang B. · 2026-08-11

   open access unreviewed
10. 10
    A comprehensive review of small molecule drugs approved by the FDA in 2025: advance and prospect.

    Bai YR, Li R, Zhang XH, Seng DJ, Xu Y, Zhang SY, Yuan S. · 2026-07-20

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.